On the pathogenesis of the secondary hyperaldosteronism of the Bartter syndrome.
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D000471:Alkalosis / Q000209:etiology; D001706:Biopsy; D004035:Diet Therapy; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology*; D006965:Hyperplasia / Q000209:etiology; D006984:Hypertrophy / Q000209:etiology; D007008:Hypokalemia / Q000209:etiology; D007606:Juxtaglomerular Apparatus; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood / Q000652:urine; D012965:Sodium Chloride / Q000627:therapeutic use; D013577:Syndrome
D012965:Sodium Chloride; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D011188:Potassium